Denosumab
Denosumab
About this item
Full title
Denosumab
Author / Creator
Publisher
Auckland: Springer Nature B.V
Journal title
Drugs & aging, 2011-01, Vol.28 (1), p.63
Language
English
Formats
Publication information
Publisher
Auckland: Springer Nature B.V
More information
Scope and Contents
Contents
Denosumab (Prolia®) is a human recombinant monoclonal antibody that is approved for the treatment of postmenopausal osteoporosis in women at high or increased risk of fracture in the US, the EU and several other countries. Denosumab has a novel mechanism of action; it binds to receptor activator of nuclear factor κB ligand and inhibits bone resorpt...
Alternative Titles
Full title
Denosumab
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_818929910
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_818929910
Other Identifiers
ISSN
1170-229X
E-ISSN
1179-1969
DOI
10.2165/11203300-000000000-00000
How to access this item
Log in as a Library member
